The following papers were published:
-
Development of an ex vivo porcine skin model for the preclinical evaluation of subcutaneously injected biomacromolecules.
Gou S, Lapteva M, Brusini R, Flegeau K, Bourdon F, Kaya G, Faivre J, Kalia YN. Int J Pharm. 2023 Dec 15;648:123562. doi: 10.1016/j.ijpharm.2023.123562
-
Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches.
de Sá FAP, Andrade JFM, Miranda TC, Cunha-Filho M, Gelfuso GM, Lapteva M, Kalia YN, Gratieri T. Int J Pharm. 2023 Dec 15;648:123617. doi: 10.1016/j.ijpharm.2023.123617.
-
Finite sample corrections for average equivalence testing.
Boulaguiem Y, Quartier J, Lapteva M, Kalia YN, Victoria-Feser MP, Guerrier S, Couturier DL. Stat Med. 2023 Dec 19. doi: 10.1002/sim.9993.
Our communication:
-
Combination of thermoresponsive terbinafine nanocrystals-loaded thermo-sensitive gels and fractional ablative laser to improve ungual drug delivery.
Rossier, Y. N. Kalia, E. Allémann.
was presented at the SFNano Annual Meeting, December 4-6, 2023, Montpellier, France.